Data about transplants using unrelated marrow donors and cord blood units from the Registry of the C.W. Bill Young Cell Transplantation Program (Registry) are reported annually from October through September.
These data include the number of transplants performed along with the following information:
- Diagnoses for which transplants have been performed most often, which include blood cancers such as leukemia and lymphoma as well as myelodysplastic syndromes.
- Cell sources used for transplants, including bone marrow, peripheral blood stem cells (or PBSC) and cord blood.
- The racial and ethnic heritages of patients who received transplants.
Figure 2. Registry Transplants by Patient Diagnosis
Figure 3. Registry Transplants by Patient Age
Figure 4. Registry Transplants by Patient Race and Ethnicity
Figure 5. Registry Transplants by Cell Source
Figure 6. Role of Cord Blood in Registry Transplants for Minority Patients
Figure 1.
Growth in Number of Registry Transplants
View larger image (new window) Detailed Description [D]
Over the last six years, the number of transplants performed through the Registry has doubled: from 1500 transplants in the year 2000 to more than 3,200 in 2006.
Figure 2.
Registry Transplants by Patient Diagnosis
View larger image (new window) Detailed Description [D]
The five diseases for which patients received an unrelated bone marrow or cord blood unit transplant most often during 2006 are listed below.
- Acute Lymphoblastic Leukemia (ALL): 17% of all transplants
- Acute Myelogenous Leukemia (AML): 30% of all transplants
- Myelodysplastic Syndromes (MDS): 13% of all transplants
- Non-Hodgkin’s Lymphoma (NHL): 11% of all transplants
- Chronic Myelogenous Leukemia (CML): 5% of all transplants
Since 2000, the numbers of transplants has increased steadily for patients who were diagnosed with AML, MDS, and NHL.
Figure 3.
Registry Transplants by Patient Age
View larger image (new window) Detailed Description [D]
From 1997 through 2006, the number of transplants performed for all age groups increased, with significant growth for patients 50 - 59 years.
Figure 4.
Registry Transplants by Patient Race and Ethnicity
|
|
|
|
|
|
For the last several years, transplants have increased steadily for patients of all racial and ethnic heritages.
Figure 5.
Registry Transplants by Cell Source
View larger image (new window) Detailed Description [D]
During the year 2006, nearly 450 transplants used cord blood units. Also, more than 850 transplants were performed using bone marrow and nearly 1,900 transplants used peripheral blood stem cells.
Figure 6.
Role of Cord Blood in Registry Transplants for Minority Patients
View larger image (new window) Detailed Description [D]
In 2006, cord blood was used to help 26% of minority patients in need of a life-saving transplant.